Premium
Neonatal cytokines and coagulation factors in children with cerebral palsy
Author(s) -
Nelson Karin B.,
Dambrosia James M.,
Grether Judith K.,
Phillips Terry M.
Publication year - 1998
Publication title -
annals of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.764
H-Index - 296
eISSN - 1531-8249
pISSN - 0364-5134
DOI - 10.1002/ana.410440413
Subject(s) - cerebral palsy , coagulation , medicine , pediatrics , physical medicine and rehabilitation
Abstract We explored the association of inflammatory mediators and markers of autoimmune and coagulation disorders with cerebral palsy (CP), examinig 53 analytes in dried neonatal blood of 31 children with spastic CP, most born at term, and 65 control children. Ultramicroanalysis was performed by recycling immunoaffinity chromatography coupled with laser‐enhanced fluorescence and chemiluminescence detection. Reactive antibodies to lupus anticoagulant, anticardiolipin, antithrombin III, and the translational product of the factor V Leiden mutation were isolated by recycling immunoaffinity chromatography and measured by capillary electrophoresis with chemiluminescence‐enhanced immunoassay. Higher concentrations of interleukins (ILs) 1, 8, 9, tumor necrosis factor‐α, and RANTES were observed in these children with CP than in any control child. There were also substantial elevations of IL‐6, 11, 13, and other chemokines and colony‐stimulating factors in children with CP. Antiphospholipid antibody was present in a titer of 1:100 or greater in 4 children with CP and no control child. Using cuts empirically chosen by recursive partitioning, we found higher concentrations of antibody to antithrombin III, to a translational product of factor V Leiden mutation, and to proteins C and S in children with CP than in controls. We conclude that inflammation and these coagulation abnormalities, which have interacting pathways, are important in the etiology of CP.